Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare epilepsy typically characterized by isolated focal motor and somatosensory seizures. Less frequently other focal seizure types, with or without secondary generalization, have been described. The seizures usually happen when the patient is awake and take a benign course. The condition is transitory, interictal examinations are normal, and there is usually no family history of epilepsy.
Biomarker and diagnostic research for benign focal seizures of adolescence has been reported in the published literature.
No clinical trials have been registered for benign focal seizures of adolescence.
48 publications have been identified in PubMed for benign focal seizures of adolescence. Research spans Case Report / Case Series (27%), Basic Science / Preclinical (25%), and Epidemiology / Natural History (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 13 | 27% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 5:40 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
12 |
25% |
Disease patterns and progression | 10 | 21% |
Research summaries | 5 | 10% |
Clinical study results | 4 | 8% |
Testing and diagnosis research | 3 | 6% |
New treatment approaches | 1 | 2% |
Totapally BR (2026). [PMID: 40418293](https://pubmed.ncbi.nlm.nih.gov/40418293/). *Pediatr Cardiol*. [Epidemiology / Natural History]
Sivaji AR (2026). [PMID: 41662827](https://pubmed.ncbi.nlm.nih.gov/41662827/). *J Sleep Res*. [Case Report / Case Series]
Goyal S (2026). [PMID: 42087646](https://pubmed.ncbi.nlm.nih.gov/42087646/). *Neurol India*. [Review / Meta-Analysis]
İriş M (2026). [PMID: 41570778](https://pubmed.ncbi.nlm.nih.gov/41570778/). *Seizure*. [Epidemiology / Natural History]
Martin D (2026). [PMID: 41791112](https://pubmed.ncbi.nlm.nih.gov/41791112/). *JMIR Pediatr Parent*. [Epidemiology / Natural History]
Elsheikh M (2026). [PMID: 41889480](https://pubmed.ncbi.nlm.nih.gov/41889480/). *Radiol Case Rep*. [Case Report / Case Series]
Choudhary RK (2026). [PMID: 41960541](https://pubmed.ncbi.nlm.nih.gov/41960541/). *Bioinformation*. [Epidemiology / Natural History]
Ortiz S (2026). [PMID: 41351427](https://pubmed.ncbi.nlm.nih.gov/41351427/). *Epilepsia*. [Basic Science / Preclinical]
Zheng X (2026). [PMID: 42266542](https://pubmed.ncbi.nlm.nih.gov/42266542/). *Front Pediatr*. [Epidemiology / Natural History]
Aires Martins I (2026). [PMID: 41961319](https://pubmed.ncbi.nlm.nih.gov/41961319/). *Eur J Pediatr*. [Epidemiology / Natural History]
AI-curated news mentioning benign focal seizures of adolescence
Updated Sep 18, 2026
Xenon Pharmaceuticals has paused psychiatric trials of azetukalner due to adverse psychosis events, despite its advancement towards FDA review for treating focal seizures. Analysts remain optimistic about the drug's potential $2 billion market opportunity in epilepsy.